Your browser doesn't support javascript.
loading
Treatment sequences for advanced renal cell carcinoma: A health economic assessment.
Deniz, Baris; Ambavane, Apoorva; Yang, Shuo; Altincatal, Arman; Doan, Justin; Rao, Sumati; Michaelson, M Dror.
  • Deniz B; Evidera, Inc., Bethesda, Maryland, United States of America.
  • Ambavane A; Evidera, Inc., London, England, United Kingdom.
  • Yang S; Bristol-Myers Squibb, Princeton, New Jersey, United States of America.
  • Altincatal A; Evidera, Inc., Bethesda, Maryland, United States of America.
  • Doan J; Bristol-Myers Squibb, Princeton, New Jersey, United States of America.
  • Rao S; Bristol-Myers Squibb, Princeton, New Jersey, United States of America.
  • Michaelson MD; Massachusetts General Hospital Cancer Center, Hematology/Oncology, Boston, Massachusetts, United States of America.
PLoS One ; 14(8): e0215761, 2019.
Article en En | MEDLINE | ID: mdl-31465470

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Análisis Costo-Beneficio / Neoplasias Renales Tipo de estudio: Health_economic_evaluation / Prognostic_studies Límite: Humans Idioma: En Año: 2019 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Análisis Costo-Beneficio / Neoplasias Renales Tipo de estudio: Health_economic_evaluation / Prognostic_studies Límite: Humans Idioma: En Año: 2019 Tipo del documento: Article